NeoA, the first social therapy network of its kind, is on a mission to help people all over the world facing many struggles in life.

The International Association of Eating Disorder Professionals Foundation (iaedp) presents a competition to promote maintaining a healthy body image.

France's largest privately held pharmaceutical company will move forward into Phase I clinical studies with the jointly-discovered High Impact AMPAKINE® compound S47445 (CX1632.